High materiality7/10
Moderna price target raised to $77 from $69 at Piper Sandler
Why it may matterVerify against the original reporting
Upside potential supported by the target upgrade.
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Piper Sandler raises Moderna target to $77 from $69.
- Piper Sandler raises MRNA target
- MRNA price target $77
Key facts
- 01
Target: $77
- 02
Posted price: $67.66
- 03
Analyst firm: Piper Sandler
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.